Enter your login e-mail to the account
Search
Search parameters
Search results
- The transferability of pharmacoeconomic studies results between countries
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. MUDr. Róbert Babeľa, PhD.
(1/2009, Pharmacoeconomics ) - Overview of results in selected in pharmacoeconomic study of ACEi ramipril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(2/2009, Pharmacoeconomics ) - Overview of results in selected in pharmacoeconomic study of ACEi perindopril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(3/2009, Pharmacoeconomics ) - ECONOMIC EVALUATION IN HEALTHCARE SYSTEM
doc. PhDr. Róbert Babeľa, PhD., prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská, PharmDr. Tomáš Tesař, PhD.
(6/2008, Pharmacoeconomics )
- PHARMACOECONOMIC EVALUATION OF DOCETAXEL IN INDUCTION CHEMOTHERAPY OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
PharmDr. Dominik Tomek, MPH, MUDr. Milan jamárik
(1/2008, Review articles ) - Health technology assessment and value for money in drug policy
PharmDr. Martin Višňanský, MBA, PhD., MSc., Mgr. Radoslav Suchovič
(2/2017, Main topic ) - Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic )